CuraScientific Corp (CSTF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCuraScientific Corp (CSTF) trades at $0.0001. CuraScientific Corp, founded in 2020 and based in Coachella, California, specializes in the production, distribution, and retail of cannabis products under JW Brands and Chad Enterprises. Sector: Healthcare.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for CSTF: CSTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
CuraScientific Corp (CSTF) Healthcare & Pipeline Overview
CuraScientific Corp. (CSTF), established in 2020, operates within the healthcare sector, focusing on the production, distribution, and retail of cannabis, CBD, kava, and kratom products under its JW Brands and Chad Enterprises labels from its Coachella, California base. The company navigates the evolving specialty and generic drug manufacturing landscape.
What Is the Investment Thesis for CSTF?
CuraScientific Corp. (CSTF) operates in the dynamic and growing market for cannabis and botanical products, positioning itself through its JW Brands and Chad Enterprises labels. A key value driver is its diversified product portfolio, which includes cannabis, CBD, kava, and kratom, potentially mitigating risks associated with reliance on a single product category. The company's relatively recent founding in 2020 allows for agility in adapting to market trends and regulatory changes within the specialty drug manufacturing and retail sectors. However, the company's current financial metrics present significant challenges, including a negative profit margin of -15299.2% and a gross margin of -3298.1%, indicating substantial operational inefficiencies or early-stage investment without corresponding revenue. The market capitalization of $0.00B suggests a very nascent or illiquid market presence. Growth catalysts would hinge on successful market penetration for its brands, potential expansion into new geographic markets, or strategic partnerships to improve distribution. Risks include intense competition, evolving regulatory landscapes for cannabis and other botanicals, and the critical need to achieve profitability and positive gross margins. The OTC Other tier listing also implies challenges with liquidity and disclosure, requiring thorough due diligence from investors.
Based on FMP financials and quantitative analysis
CSTF Key Highlights
Market Capitalization: $0.00B, indicating a very small or illiquid market presence.
- Profit Margin: -15299.2%, reflecting substantial net losses relative to revenue.
- Gross Margin: -3298.1%, suggesting that the cost of goods sold significantly exceeds revenue.
- Beta: -3.96, indicating an inverse relationship with the broader market, though this could be skewed by low liquidity or specific trading patterns.
- Employee Count: 2 employees, highlighting a highly lean operational structure.
Who Are CSTF's Competitors?
CSTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CSTF's Key Strengths?
Diversified product portfolio including cannabis, CBD, kava, and kratom.
- Established brand names (JW Brands, Chad Enterprises) in the cannabis market.
- Agile operational structure with a small employee base (2 employees).
What Are CSTF's Weaknesses?
Extremely negative profit margin (-15299.2%) and gross margin (-3298.1%) indicating severe unprofitability.
- Very small market capitalization ($0.00B) suggesting limited scale and market presence.
- Limited employee base (2 employees) may constrain growth and operational capacity.
- OTC Other tier listing implies challenges with liquidity and disclosure.
What Are the Key Risks for CSTF?
Sustained unprofitability, as evidenced by extremely negative profit and gross margins, threatening long-term viability.
- Intense competition in the rapidly evolving cannabis and botanical products market from larger, better-funded entities.
- Adverse changes in regulatory frameworks for cannabis, CBD, kava, or kratom could impact operations and market access.
- Challenges related to liquidity and investor confidence due to trading on the OTC Other tier with unknown disclosure status.
- Limited resources and a small employee base (2 employees) may hinder scalability and ability to capitalize on growth opportunities.
What Threats Does CSTF Face?
- Intense competition from larger, more established players in the cannabis and botanical markets.
- Evolving and complex regulatory landscape for cannabis, CBD, kava, and kratom.
- Challenges in achieving profitability and positive cash flow given current financial metrics.
- Liquidity and investor confidence issues associated with OTC Other tier trading.
What Are CSTF's Competitive Advantages?
- Proprietary brand names (JW Brands, Chad Enterprises) in the cannabis market.
- Diversified product portfolio including cannabis, CBD, kava, and kratom, reducing reliance on a single product.
- Early mover advantage in specific segments of the evolving botanical products market since its founding in 2020.
What Does CSTF Do?
CuraScientific Corp., headquartered in Coachella, California, was established in 2020, marking its entry into the rapidly evolving market for cannabis and related botanical products. The company's core business revolves around the comprehensive lifecycle of cannabis products, encompassing their production, distribution, and retail operations. These offerings are primarily marketed under two distinct brand names: JW Brands and Chad Enterprises, catering to specific segments within the cannabis consumer base. Beyond its foundational focus on cannabis, CuraScientific has strategically diversified its product portfolio to include other botanical derivatives known for their therapeutic or recreational properties. This expansion includes cannabidiol (CBD), a non-psychoactive compound derived from cannabis, which has gained significant traction for its potential health benefits. Furthermore, the company deals in kava and kratom, two botanicals with established traditional uses, broadening its appeal to a wider consumer demographic interested in natural wellness and alternative products. The company's operational history includes a significant corporate rebranding effort; prior to April 2023, CuraScientific Corp. conducted its business activities under the name Boon Industries, Inc. This name change signifies an evolution in its corporate identity and potentially its strategic direction within the healthcare and specialty drug manufacturing sectors. Operating with a lean team of two employees, CuraScientific manages its supply chain and market presence from its base in Coachella, positioning itself to serve the burgeoning demand for regulated cannabis and botanical products across various distribution channels. The company's strategy appears to center on leveraging its brand presence and product diversification to capture market share in a competitive and highly regulated industry.
What Products and Services Does CSTF Offer?
- Produces cannabis products under the JW Brands and Chad Enterprises names.
- Distributes cannabis products to various retail channels.
- Engages in the retail sale of cannabis products.
- Offers cannabidiol (CBD) products.
- Provides kava products.
- Sells kratom products.
- Operated as Boon Industries, Inc. prior to April 2023.
How Does CSTF Make Money?
- Generates revenue through the sale of cannabis products under its proprietary brands.
- Sells diversified botanical products including CBD, kava, and kratom.
- Operates across the production, distribution, and retail segments of the cannabis and botanical market.
What Industry Does CSTF Operate In?
CuraScientific Corp. operates within the "Drug Manufacturers - Specialty & Generic" industry, specifically focusing on the production and distribution of cannabis, CBD, kava, and kratom. This segment is characterized by rapid innovation, evolving consumer preferences, and a complex regulatory environment, particularly concerning cannabis. The broader healthcare sector is witnessing increasing demand for alternative wellness products, driving growth in botanical extracts. However, the market is highly fragmented with numerous players ranging from large pharmaceutical companies exploring cannabinoid-based drugs to smaller, specialized producers. CuraScientific's positioning with its JW Brands and Chad Enterprises names places it in direct competition with established cannabis brands and emerging botanical product companies. The challenge for CuraScientific lies in differentiating its offerings and achieving economies of scale in a market where regulatory compliance and product quality are paramount.
Who Are CSTF's Key Customers?
- Consumers seeking recreational cannabis products.
- Individuals interested in the wellness benefits of CBD, kava, and kratom.
- Retail dispensaries and other distribution partners for its branded products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
CuraScientific Corp operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Coachella, US. The company is led by CEO Samuel L. Berry. CSTF has traded publicly since 1998.
Key Financial Metrics
Return on equity for CuraScientific Corp stands at 7.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -71.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
CuraScientific Corp's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 66.06 places it in the safe zone, indicating low near-term bankruptcy risk.
CSTF Financials
CSTF Latest News
No recent news available for CSTF.
CSTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CSTF.
Price Targets
Wall Street price target analysis for CSTF.
CSTF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CSTF; grades run from A+ (80-100) to F (below 30).
Leadership: Samuel L. Berry
CEO
Samuel L. Berry serves as the leader of CuraScientific Corp., overseeing its operations and strategic direction from its Coachella, California headquarters. With the company operating with a lean team of two employees, Mr. Berry's role likely encompasses a broad range of responsibilities, from product development and distribution strategy to financial oversight and regulatory compliance within the specialized healthcare and botanical products sector. His leadership is critical in navigating the complex landscape of cannabis, CBD, kava, and kratom markets, which are characterized by evolving regulations and intense competition.
Track Record: Under Samuel L. Berry's leadership, CuraScientific Corp. has established its presence in the cannabis and botanical products market since its founding in 2020, including the rebranding from Boon Industries, Inc. in April 2023. His tenure has seen the company focus on the production, distribution, and retail of products under JW Brands and Chad Enterprises, alongside offerings in CBD, kava, and kratom. Specific achievements, strategic decisions, or financial milestones directly attributable to his leadership are not detailed in the provided information.
CSTF OTC Market Information
CuraScientific Corp. (CSTF) trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial health, corporate governance, and minimum share prices, companies on the OTC Other tier have minimal to no public disclosure requirements. This tier is typically home to shell companies, defunct entities, or companies with limited operations and financial information. Investors in OTC Other stocks face significantly higher risks due to the lack of transparency and regulatory oversight compared to higher OTC tiers like OTCQB or OTCQX, let alone national exchanges.
- OTC Tier: OTC Other
- Extreme illiquidity and difficulty in trading shares.
- Lack of public financial disclosure and transparency (Disclosure Status: Unknown).
- Higher susceptibility to fraud and market manipulation due to minimal oversight.
- Difficulty in obtaining reliable information for investment decisions.
- Limited analyst coverage and institutional investor interest.
- Verify current financial statements and audit reports, if any are available.
- Research any past or ongoing regulatory actions or enforcement against the company.
- Investigate the background and legitimacy of management beyond basic names.
- Assess the actual operational status and revenue generation capabilities.
- Examine share structure, outstanding shares, and any potential dilution.
- Scrutinize any claims of partnerships or product development for factual basis.
- Confirm the company's legal standing and registration with state authorities.
- Existence of specific product brands (JW Brands, Chad Enterprises) and product categories (cannabis, CBD, kava, kratom).
- Stated physical headquarters in Coachella, US.
- Identified founding year (2020) and a corporate name change in April 2023.
- Identified CEO (Samuel L. Berry) and employee count (2).
Common Questions About CSTF (Healthcare)
What specific products does CuraScientific Corp offer in the healthcare and wellness market?
CuraScientific Corp. specializes in a diversified portfolio of botanical products aimed at the healthcare and wellness market. Its primary offerings include a range of cannabis products, which are marketed under two distinct brand names: JW Brands and Chad Enterprises. These cannabis products encompass various forms for production, distribution, and retail.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited by the provided source data, particularly regarding detailed financial performance, CEO background, and specific market share data.
- The company's OTC Other tier status implies significant limitations in publicly available information and liquidity.